Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04169919Completed
Open-label trial of povidone-iodine in epidemic keratoconjunctivitis (EKC) (2 arms), sponsored by Minia University. Primary endpoints: Ocular symptoms of epidemic keratoconjunctivitis at 2 weeks and Ocular signs of epidemic keratoconjunctivitis at 2 weeks. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04169919.